Similarly, a SMO knockdown human pancreatic cancer stem cell demonstrated a decrease in the expression of E-cadherin and increase in the expression of SNAI1 and N-cadherin [133]. The gene discussed is SNAI1; the disease is pancreatic neoplasm.